08 SETIEMBRE

08 SETIEMBRE

08 SEPTEMBER

Humanities, Social Sciences & Thought Biology PSALife sciences: general issuesPSADBioethics
🎙 GESTION DEL CONOCIMIENTO INSNSB 👥 778 📅 September 21, 2026 ⏱ 42 min 👁 1 📄 expert opinion 🧭 2026-09-21
Available in: English (current) Français

Keywords

Institutional Ethics CommitteeClinical TrialsPeruvian RegulationInformed ConsentResearch Ethics

Summary

This video is a training session conducted in Spanish on institutional ethics and research committees (Comités de Ética en Investigación, CEI) in Peru. The speaker, a technical secretary of the ethics committee at the Instituto Nacional de Salud del Niño San Borja, explains the legal framework under which these committees operate. He covers the Peruvian regulatory norms, including Decreto Supremo 021-2017-SA and its modification 028-2023, which govern clinical trials. The composition of a CEI is detailed: a multidisciplinary team of at least five titular members with expertise in health, behavioral and social sciences, ethics, legal aspects, and community representation. The main functions of the committee are described, such as evaluating protocols, assessing risk-benefit ratios, ensuring informed consent, and monitoring ongoing studies. The presentation also emphasizes the importance of independence, conflict of interest management, and the accreditation process through the Instituto Nacional de Salud. Practical insights are shared from the speaker’s daily experience, including meeting organization, document handling, and follow-up of research projects. The session concludes with a Q&A segment addressing questions about virtual vs. in-person meetings, committee renewal, and the role of reviewers. Overall, the video serves as an educational resource for healthcare professionals involved in research ethics in Peru.

200 words

Critical Evaluation

Value of the Information & Strength of the Argument

The value of this video lies in its practical, insider perspective on the functioning of a Peruvian ethics committee. The speaker provides concrete details about documentation requirements, meeting logistics, and the step-by-step assessment process, which would be highly useful for new committee members or researchers preparing protocols. The argumentation is based on the speaker’s professional experience and explicit reference to national regulations, but it lacks critical analysis. For instance, the speaker states requirements without discussing potential weaknesses or comparing them to international standards. The justification for the committee’s decisions is presented as straightforward compliance with rules, without addressing ethical dilemmas or controversies. Nevertheless, the presentation is coherent and logically structured, moving from normative foundations to operational specifics.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is moderate. The speaker cites the relevant Peruvian decrees (DS 021-2017-SA, DS 028-2023) and mentions international documents such as the Declaration of Helsinki and the Belmont Report, but does not provide exact citations or a critical assessment of these sources. The information appears accurate based on the regulatory texts, but the lack of footnotes or direct references limits verification. The title ‘08 SETIEMBRE’ is merely a date and does not indicate the subject matter, which reduces its utility as a searchable resource. The content is authoritative in the sense that it comes from a practitioner, but it is not a systematic review or evidence-based analysis. No comments are available to gauge public reception.

248 words

Title / Content Match

The title is a date (08 September) and does not describe the content; it is likely a session identifier. The video content is about ethics committees in research, so the title is not informative.

Quality & Reliability

6/10

The presentation is a practical overview of Peruvian regulations and ethics committee operations, provided by a technical secretary with direct experience. It is informative but lacks critical depth and references only a few documents without detailed analysis.

Key Moments

Cited Sources

  • Decreto Supremo 021-2017-SA — Reglamento de Ensayos Clínicos del Perú, articles 58-66.
  • Decreto Supremo 028-2023-SA — Modification of the clinical trials regulation.
  • Declaración de Helsinki — Ethical principles for medical research involving human subjects.
  • Informe Belmont — Principles of respect for persons, beneficence, and justice.
  • Pautas éticas internacionales (CIOMS) — International ethical guidelines for health-related research.
  • Registro Peruano de Ensayos Clínicos (RPEC) — National registry for clinical trial accreditation and oversight.

Concurring Sources

Contribution & Novelties

The video offers a unique insider perspective on the operational aspects of a Peruvian institutional ethics committee, including administrative routines, accreditation documentation, and the balance between independence and institutional constraints. This practical orientation is rarely captured in official guidelines and is valuable for practitioners. The speaker shares his own experience as a technical secretary, which adds authenticity but does not constitute novel scientific knowledge.

Pour aller plus loin :

  • Belmont Report — Foundational ethical principles for research with human subjects; aligns with the video’s emphasis on respect, beneficence, and justice.
  • Declaration of Helsinki — Core international guideline for medical research ethics, referenced in the video.
  • Institutional Review Board — Equivalent structure in the US; provides comparative context for ethics committee functions.

121 words

Radar Profile

The radar profile shows moderate scores across all dimensions, with fiabilite_globale being the highest (7). This reflects the video's strength as a reliable exposition of Peruvian regulations but weaknesses in depth and technical complexity. The low niveau_technique suggests it targets a general audience rather than specialists. Overall, the profile indicates a useful educational resource rather than a cutting-edge scientific contribution.

Reliability 7/10